Purchase Order 75N93023P00592
- Not listed
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of EXPIFECTAMINE reagent kits for $15,263.70 with a completion date of September 24, 2020. The contract does not have a set-aside designation. Life Technologies is a leading provider of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $18,225 purchase order to Life Technologies Corporation for EXPIFECTAMINE transfection reagent kits. The fixed-price contract runs from August 31, 2023 through November 30, 2023 for delivery of the 10-liter kits to a facility in Grand Island, New York. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the procurement of an EXPIFECTAMINE 293 Transfection Kit. The contract has a ceiling value of $14,825.60 and a completion date of July 7, 2015. The contract was awarded on June 24, 2015 and did not utilize any set-aside designations. As a...
- This is a $6,620 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the supply of an EXPIFECTAMINE 293 Transfection Kit, a specialized reagent used in biomedical research and genetic analysis. The award does not involve any set-aside designations. Life Technologies...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the procurement of 5 Expifectamine Transfxn Reagent Kits, with a ceiling value of $23,643.00. The contract has an ultimate completion date of August 20, 2021 and was awarded on July 20, 2021. No set-aside was used...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the procurement of Expifectamine Transfection Kit and EXPI293 Expression Medium. The contract has a ceiling value of $95,780.00 and a period of performance from October 1, 2018 to September 30, 2019. This order was competed on the open market and did...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for EXPIFECTAMINE TRANSFXN KIT 10L. The contract has a potential value of $4,552.00 and a completion date of July 12, 2018. Life Technologies Corporation is a division of the parent company Thermo Electron Corporation,...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the procurement of ExpiFectamine transfection kits and OptiMEM media, which are used in the production of recombinant proteins and monoclonal antibodies for NIAID's Vaccine Research Center. The total ceiling value of the contract is...
- This federal contract award, with a ceiling value of $6,620.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the procurement of the EXPIFECTAMINE 293 TRANSFECTION KIT CAT#A14524, which is used in biomedical research and genetic analysis. The contract is a firm fixed-price purchase order awarded on October 30, 2014, with a completion date of November 29, 2014....
- This is a $24,570.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the Department of Health and Human Services to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is a Blanket Purchase Agreement (BPA) call order for the Expifectamine transfection kit, a reagent used for genetic engineering and cell culture applications. As the prime contractor, Life Technologies is responsible for providing the...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for EXPIFECTAMINE Transfection Reagent Kits. The $56,950.00 contract has a completion date of June 30, 2023 and does not utilize any set-aside designations. The original solicitation was issued as a simplified acquisition for commercial items under FAR Part 13. Life Technologies Corporation, as a manufacturer of scientific instruments and reagents, has a history of supporting NIAID and other federal agencies through prime contracts and subcontracts for specialized biotechnology products and services related to medical research, healthcare, and criminal justice initiatives.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
EXPIFECTAMINE TRANSFXN KIT - BRAND NAME ONLY | RFQ-NIAID-23-2170565 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 4/26/23, 11:42 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.0k | 5/10/23 |